The Latest in Breast Cancer

Oncology Practice

Hyperlipidemia diagnosis protects against breast cancer

October 11, 2017

Breast Cancer

The Journal of Community and Supportive Oncology

David Henry's JCSO podcast, September-October 2017

October 1, 2017

Oncology Practice

FDA approves abemaciclib for advanced breast cancer

September 28, 2017

Oncology Practice

HER2 status differed between primary tumor and CTCs in 18.8% of women with MBC

September 28, 2017

The Journal of Community and Supportive Oncology

Two cases of possible remission in metastatic triple-negative breast cancer

September 28, 2017

Oncology Practice

GEICAM/2006-10: Adjuvant fulvestrant/anastrozole role in early breast cancer uncertain

September 25, 2017

Breast Cancer

Oncology Practice

‘Very daring study’ of neoadjuvant AI/CDKi combo in early BC is hypothesis generating

September 23, 2017

Breast Cancer

Oncology Practice

MONARCH 3: Abemaciclib plus AI boosts PFS in HR+/HER2- breast cancer

September 19, 2017

Breast Cancer

Oncology Practice

LORELEI sings praises of neoadjuvant taselisib/letrozole in ER+/HER2– breast cancer

September 15, 2017

Breast Cancer

Oncology Practice

Surgeons strongly influenced chances of contralateral prophylactic mastectomy

September 13, 2017

Breast Cancer

Oncology Practice

Ten-year outcomes support skipping axillary lymph node dissection with positive sentinel nodes

September 12, 2017

Breast Cancer

The Journal of Community and Supportive Oncology

Assessing a multidisciplinary survivorship program in a group of predominantly Hispanic women with breast cancer

September 8, 2017

The Journal of Community and Supportive Oncology

An ASCO 2017 recap: significant advances continue

September 8, 2017

Oncology Practice

Focus on lifestyle to manage menopause symptoms after breast cancer

August 30, 2017

Oncology Practice

FDA expands approval of fulvestrant for HR+/HER2– advanced breast cancer

August 30, 2017

Breast Cancer